Related Experiment Video

Updated: Feb 10, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.2K

Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene

Feng Cao1, Tai-Yi Jin, Yuan-Fen Zhou

  • 1Department of Occupational Health and Toxicology, School of Public Health, Fudan University, Shanghai 200032, China.

Biomedical and Environmental Sciences : BES
|May 6, 2006
PubMed
Abstract

Insights

Genistein and daidzein inhibit prostate cancer cell growth in a dose-dependent manner. These compounds influence cell cycle, apoptosis, and gene expression, suggesting PTEN gene plays a key role in their anti-cancer effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Prostate cancer remains a significant health concern globally.
  • Genistein and daidzein are soy isoflavones with potential anti-cancer properties.
  • Understanding their mechanisms of action is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the inhibitory effects of genistein and daidzein on prostate cancer cell lines.
  • To elucidate the molecular mechanisms underlying their anti-proliferative actions.

Main Methods:

  • Prostate cancer cell lines (LNCaP and PC-3) were treated with genistein and daidzein.
  • Cell viability assessed via MTT assay; cytotoxicity by LDH test.
  • Cell cycle analysis performed using flow cytometry (FCM).
  • Gene expression of PTEN, ERalpha, ERbeta, AR, and VEGF analyzed by RT-PCR.

Main Results:

  • Genistein and daidzein reduced prostate cancer cell viability in a time- and dose-dependent manner.
  • Genistein altered cell cycle progression (G2/M in PC-3, S in LNCaP).
  • Daidzein increased apoptosis in LNCaP cells.
  • Both compounds modulated PTEN, AR, and VEGF gene expression, with varying effects on ER genes.

Conclusions:

  • Genistein and daidzein exhibit significant anti-prostate cancer cell activity.
  • PTEN gene expression appears central to the inhibitory effects.
  • Potential involvement of the Akt pathway and down-regulation of AR and VEGF.

More Related Videos

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Published on: October 20, 2015

14.6K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.6K

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
13.1K
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
24.9K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K